Searched for
VACCINE TECH TRANSFER
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- At Global AI Summit, India stakes claim as tech’s safe harborIndia is hosting a Global AI Summit to showcase its potential as a leading AI technology destination. The nation highlights its successful ...
- Bharat Biotech, Biofabri in tech transfer deal for TB vaccineMTBVAC, the TB vaccine, has undergone Phase I and II clinical trials in India. The vaccine has demonstrated safety and immunogenicity. Base...
- Global roll-out of 12 billion COVID-19 vaccine doses largest-ever but access an issue: WHOAddressing the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) virtually on Thursday, he flagged t...
- Dr Reddy's finding it hard to sell Russian-made Sputnik V vaccine in India"In terms of the market situation, the private market overall has seen a sharp dip and Sputnik V has been solely private. The market has se...
- Ready to partner with interested countries for tech transfer, manufacture of vaccines, says IndiaUnder the Quad framework, India is also partnering with Australia, Japan and the United States to expand the vaccine manufacturing capacity...
- WHO-backed vaccine hub for Africa to copy Moderna COVID-19 shotModerna said last October it would not enforce patents related to its shot during the pandemic, raising hopes that other companies might be...
- IIL may start supplying 20 lakh doses of Covaxin by September: GovtOn the production plan of Covaxin at various facilities, NITI Aayog member (Health) Dr V K Paul said there were some initial hiccups relate...
- Compulsory licensing for Covid vaccines not very attractive option; tech transfer is the key: GovtNiti Aayog Member V K Paul, the Chair of the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), noted that technology t...
- Govt, Pfizer are working together for the earliest possible import of vaccines: NITI Aayog's VK PaulStating facts about Centre’s initiatives to buy vaccines from abroad, Paul said the central government has remained engaged continuously wi...
- Moderna, Pfizer can’t supply to India due to pre-orders: Government“We have been speaking to Pfizer and Moderna in terms of regulatory pathways and on procurement level," said Lav Agrawal, joint secretary a...
- Covax seeks faster WHO approval for CovaxinIn a meeting held on Friday, Covax facility experts from India and other countries recommended approval for the India-developed Covaxin and...
- Vaccine tech transfer hard, next six months key in Covid fight, says leading vaccine makersOn Friday, senior executives from companies such as Moderna, GSK and Bharat Biotech addressed various issues on Covid vaccines, including e...
- J&J COVID-19 vaccine expected to be imported to India by July - reportIndia has said it would fast-track emergency approvals for COVID-19 vaccines authorised by Western countries and Japan, paving the way for ...
- DRL's GV Prasad on vaccine ramp-up, Sputnik plan and price cap removal"I think the government rightly took care of the most vulnerable sections initially. But now, those who do not need to be subsidised should...
- Covid-19: More Indian cos could begin manufacturing Sputnik vaccineIt is indicative that companies like Serum Institute of India (SII), Panacea Biotec and Biocon may also get into manufacturing Sputnik, not...
- Mounting a fightback: Covid-19 vaccine developers reach last leg of trialsAs US regulators tighten the scrutiny around approvals, companies have announced their intention to put their trial data in public domain f...
- Can’t let rich nations buy up initial Covid-19 vaccines: Melinda GatesMelinda Gates, cofounder of the Bill & Melinda Gates Foundation said Covid had resulted in 25 years of progress on vaccinations being wiped...
- Hyderabad company, Australian varsity partner for vaccineScientists from India and Australia will develop a ‘live attenuated SARS – CoV-2 vaccine’ using the latest codon deoptimisation technology,...
Load More
